Transapical ProtekDuo Rapid Deployment Cannula as Temporary Left Ventricular Assist Device in a Jehovah's Witness Patient

Published:December 11, 2020DOI:https://doi.org/10.1053/j.jvca.2020.12.009
      Temporary left ventricular support aims to decompress the left ventricle and provide adequate forward flow into the arterial circulation. This can be accomplished with endovascular devices such as the Impella with an internal motor, or with the implementation of cannulae to drain the left ventricle or left atrium and then return to the arterial circulation using an external pump. In this report, the authors describe the transesophageal echocardiography–guided placement of a single-cannula system with the Protek Duo RD (TandemLife, LivaNova) via a left ventricular apical approach to provide minimally invasive left ventricular support in a high-risk Jehovah's Witness patient.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cardozo S
        • Ahmen T
        • Belgrave K.
        Impella induced massive hemolysis: Reemphasizing echocardiography guidance for correct placement.
        Case Rep Cardiol. 2015; 2015464135
        • Sibbald M
        • Džavík V.
        Severe hemolysis associated with use of the Impella LP 2.5 mechanical assist device.
        Catheter Cardiovasc Interv. 2012; 80: 840-844
        • Bottrell S
        • Bennett M
        • Augustin S
        • et al.
        A comparison study of haemolysis production in three contemporary centrifugal pumps.
        Perfusion. 2014; 29: 411-416
        • Palanzo DA
        • El-Banayosy A
        • Stephenson E
        • et al.
        Comparison of hemolysis between CentriMag and RotaFlow rotary blood pumps during extracorporeal membrane oxygenation.
        Artif Organs. 2013; 37: E162-E166
        • Sobieski MA
        • Giridharan GA
        • Ising M
        • et al.
        Blood trauma testing of CentriMag and RotaFlow centrifugal flow devices: A pilot study.
        Artif Organs. 2012; 36: 677-682
        • Akanni OJ
        • Takeda K
        • Truby LK
        • et al.
        EC-VAD: Combined use of extracorporeal membrane oxygenation and percutaneous microaxial pump left ventricular assist device.
        ASAIO J. 2019; 65: 219-226
        • Aggarwal V
        • Einhorn BN
        • Cohen HA.
        Current status of percutaneous right ventricular assist devices: First-in-man use of a novel dual lumen cannula.
        Catheter Cardiovasc Interv. 2016; 88: 390-396
        • Ravichandran AK
        • Baran DA
        • Stelling K
        • et al.
        Outcomes with the Tandem Protek Duo dual-lumen percutaneous right ventricular assist device.
        ASAIO J. 2018; 64: 570-572
        • Kashiwa K
        • Nishimura T
        • Saito A
        • et al.
        Left heart bypass support with the Rotaflow Centrifugal Pump as a bridge to decision and recovery in an adult.
        J Artif Organs. 2012; 15: 207-210
        • Ramlawi B
        • Anaya-Ayala JE
        • Reardon MJ.
        Transcatheter aortic valve replacement (TAVR): Access planning and strategies.
        Methodist Debakey Cardiovasc J. 2012; 8: 22-25
        • Hanke JS
        • Avsar M
        • Haverich A
        • et al.
        Heart-failing Jehovah's Witness patient successfully treated by minimally invasive LVAD implantation without any blood transfusions.
        Thorac Cardiovasc Surg Rep. 2015; 4: 21-24
        • MAQUET Cardiopulmonary
        Centrifugal Pump Rotaflow.
        Maquet Cardiopulmonary AG, Hirrlingen, Germany2020: 1-6 (Accessed November 3, 2020)
      1. Impella ventricular support systems for use during cardiogenic shock and high-risk PCI: Instructions for use and clinical reference manual.
        Abiomed, Inc., Danvers, MA2017 (I-C.3Available at: www.abiomed.com. Accessed May 27, 2020)
        • Kazui T
        • Tran PL
        • Echeverria A
        • et al.
        Minimally invasive approach for percutaneous CentriMag right ventricular assist device support using a single PROTEKDuo cannula.
        J Cardiothorac Surg. 2016; 11: 123
        • Kapur NK
        • Esposito ML
        • Bader Y
        • et al.
        Mechanical circulatory support devices for acute right ventricular failure.
        Circulation. 2017; 136: 314-326